Open Access Research article

Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)

Gemma Bruera, Katia Cannita, Daniela Di Giacomo, Aude Lamy, Thierry Frébourg, Jean Christophe Sabourin, Mario Tosi, Edoardo Alesse, Corrado Ficorella and Enrico Ricevuto*

BMC Medicine 2013, 11:59  doi:10.1186/1741-7015-11-59

Article Metrics

2682
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 52 accesses
  • Last 365 days: 729 accesses
  • All time: 2682 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information